Laurent Softic

Inserm U955, Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory viruses.

Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory viruses.

Journal: Antimicrobial agents and chemotherapy

Published: July 17, 2026

Role of respiratory small extracellular vesicles in Respiratory Syncytial Virus infection

Role of respiratory small extracellular vesicles in Respiratory Syncytial Virus infection

Journal: Virologie (Montrouge, France)

Published: November 03, 2025

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.

Journal: The Lancet. Microbe

Published: October 21, 2025

Respiratory Syncytial Virus Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Respiratory Syncytial Virus Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Journal: JAMA network open

Published: September 26, 2025

Identification and characterization of a nonpeptidic cyclophilin ligand with antiviral activity against feline and porcine α-coronaviruses.

Identification and characterization of a nonpeptidic cyclophilin ligand with antiviral activity against feline and porcine α-coronaviruses.

Journal: Veterinary research

Published: May 07, 2025

Molecular Characterization of Respiratory Syncytial Virus Infections in Elderly Patients During the 2023-2024 Season in the Era of Nirsevimab Introduction.

Molecular Characterization of Respiratory Syncytial Virus Infections in Elderly Patients During the 2023-2024 Season in the Era of Nirsevimab Introduction.

Journal: The Journal of infectious diseases

Published: November 04, 2024

Role of G3BP proteins in SARS-CoV-2 replication

Role of G3BP proteins in SARS-CoV-2 replication

Journal: Medecine sciences : M/S

Published: July 10, 2024

Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly.

Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly.

Journal: Nature communications

Published: December 13, 2022

Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.

Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.

Journal: Journal of extracellular vesicles

Published: March 11, 2022

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.

Journal: Scientific reports

Published: January 12, 2022

Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.

Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.

Journal: The British journal of dermatology

Published: November 12, 2020

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).

Journal: Antimicrobial agents and chemotherapy

Published: May 03, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026